Lack of insulin resistance in fibroblasts from subjects with polycystic ovary syndrome (Q46135692)

19 December 2017

title

Lack of insulin resistance in fibroblasts from subjects with polycystic ovary syndrome (English)

1 reference

19 December 2017

polycystic ovary syndrome

main subject

1 reference

1 reference

1 reference

6

Olefsky JM

1 reference

19 December 2017

Ciaraldi TP

1

1 reference

19 December 2017

Morales AJ

2

1 reference

19 December 2017

Hickman MG

3

1 reference

19 December 2017

Odom-Ford R

4

1 reference

19 December 2017

Yen SS

5

1 reference

19 December 2017

publication date

1 August 1998

1 reference

19 December 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Metabolism

1 reference

19 December 2017

volume

47

1 reference

19 December 2017

issue

8

1 reference

19 December 2017

page(s)

940-946

1 reference

19 December 2017

The polycystic ovary syndrome

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990348-1

Polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990348-1

Obesity and polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990348-1

Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990348-1

Insulin resistance in nonobese patients with polycystic ovarian disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990348-1

Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990348-1

Cellular mechanisms of insulin resistance in polycystic ovarian syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990348-1

Severe impairment of insulin action in adipocytes from amenorrheic subjects with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990348-1

Induction of insulin resistance by androgens and estrogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990348-1

Insulin-stimulated glucose uptake, leucine incorporation into protein, and uridine incorporation into RNA in skin fibroblast cultures from patients with diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990348-1

Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990348-1

Use of Polyethylene Glycol to Separate Free and Antibody-Bound Peptide Hormones in Radioimmunoassays†

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990348-1

Insulin action kinetics in adipocytes from obese and noninsulin-dependent diabetes mellitus subjects: identification of multiple cellular defects in glucose transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990348-1

Dysregulation of glucose transport and transporters in perfused hearts of genetically obese (fa/fa) rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990348-1

Receptors for insulin-like growth factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990348-1

Insulin activation of glycogen synthase in cultured human fibroblasts is not mediated solely via the insulin receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990348-1

Facilitative glucose transporters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990348-1

Absence of insulin receptor gene mutations in three insulin-resistant women with the polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990348-1

The tyrosine kinase domain of the insulin receptor gene is normal in women with hyperinsulinaemia and polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990348-1

Insulin resistance--mechanisms, syndromes, and implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990348-1

Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990348-1

Reduction of endogenous, ovarian and adrenal androgens with ketoconazole does not alter insulin response in the polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990348-1

Hyperinsulinemia in hyperthecosis of the ovaries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990348-1

The genetics of polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990348-1

The effects of experimental hyperinsulinemia on steroid secretion, ovarian [125I]insulin binding, and ovarian [125I]insulin-like growth-factor I binding in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990348-1

The role of insulin-like growth factor-1 (IGF-1) and IGF binding protein-1 (IGFBP-1) in the pathogenesis of polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990348-1

Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990348-1

The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990348-1

Insulin resistant and non-resistant polycystic ovary syndrome represent two clinical and endocrinological subgroups.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990348-1

Heterogeneity in beta cell activity, hepatic insulin clearance and peripheral insulin sensitivity in women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990348-1

10.1016/S0026-0495(98)90348-1

7 January 2021

Identifiers

DOI

1 reference

19 December 2017

1 reference

19 December 2017